News | July 26, 2021
Glenmark Life Sciences IPO to open on July 27, 2021
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
The IPO comprises a fresh issue of up to Rs. 11,600 million and an offer for sale of up to 7,305,245 equity shares of Rs. 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Subscribe To Our Newsletter & Stay Updated
